Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
149647-78-9
Purity
95%
Vorinostat is a histone deacetylase inhibitor used for the treatment of cutaneous manifestations in patients with progressive, persistent, or recurrent cutaneous T- cell lymphoma following prior systemic therapies.
Properties
Name
Vorinostat
Smiles
ONC(=O)CCCCCCC(=O)NC=1C=CC=CC1
Targets
Please log in to see this information
SDS
N-Hydroxy-N′-phenyloctanediamide | N-hydroxy-N'-phenyloctanediamide | N-hydroxy-N’-phenyl-octanediamide | N1-hydroxy-N8-phenyloctanediamide | SML0061 | Zolinza | saha | suberanilohydroxamic acid | suberanoylhydroxamic acid | suberoylanilide hydroxamic acid | vorinistat | vorinostat
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
N-Hydroxy-N′-phenyloctanediamide | N-hydroxy-N'-phenyloctanediamide | N-hydroxy-N’-phenyl-octanediamide | N1-hydroxy-N8-phenyloctanediamide | SML0061 | Zolinza | saha | suberanilohydroxamic acid | suberanoylhydroxamic acid | suberoylanilide hydroxamic acid | vorinistat | vorinostat
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.